EFFICACY AND SAFETY OF BEXAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Eric PasqualottoRaphaela da Silva MaintinguerSimone van de Sande-LeeGustavo Neves de AraujoFidel Silveira LealCarlos Eduardo Andrade PinheiroPublished in: Diabetes, obesity & metabolism (2023)
In this meta-analysis, the use of bexagliflozin was associated with improved clinical and laboratory measures in patients with DM2 compared to placebo, with a similar profile of side effects. These findings support the efficacy of bexagliflozin in the treatment of DM2. This article is protected by copyright. All rights reserved.